LONOPIN 40MG INJECTION 0.4 ML

LONOPIN 40MG INJECTION 0.4 ML is not recommended for people suffering from active major bleeding or a history of hypersensitivity to this drug, heparin, Benzyl alcohol, or pork products. This drug is also not advised for people with a history of heparin-induced thrombocytopenia in the past hundred days.

Suppose you are taking heparin or low molecular weight heparin while on this treatment is not recommended. Tell your healthcare provider about taking other medications or herbal supplements.

The most common adverse reactions of LONOPIN 40MG INJECTION 0.4 ML are bleeding, anemia, thrombocytopenia, diarrhea, nausea, fever, edema, breathlessness, confusion, and pain at the injection site.

LONOPIN 40MG INJECTION 0.4 ML is probably unsafe for pregnant women and their fetuses. While it is unknown if the treatment interferes with breastfeeding, it is advisable to inform your doctor before starting the treatment if you suspect pregnancy, breastfeeding, or planning to have a baby.

Store LONOPIN 40MG INJECTION 0.4 ML below 30˚C at a controlled room temperature. Please keep it in the original carton until it is ready to use. Do not freeze or store the injection for more than 28 days after its use.

It is important to inform your healthcare provider about all medications, including heparin or low molecular weight heparin, and herbal supplements you are taking, as they may interact with LONOPIN 40MG INJECTION 0.4 ML.

While on LONOPIN 40MG INJECTION 0.4 ML, get adequate rest, eat a well-balanced diet, and avoid driving or operating machines if you feel dizzy or have vision problems. Applying a cool compress at the injection site can help reduce pain and irritation.

The active ingredient in LONOPIN 40MG INJECTION 0.4 ML is Enoxaparin.

Yes, LONOPIN 40MG INJECTION 0.4 ML (Enoxaparin) is a type of low molecular weight heparin used as an anticoagulant to help prevent blood clots.

LONOPIN 40MG INJECTION 0.4 ML works by preventing existing blood clots from becoming larger and inhibiting the formation of new clots in the veins and arteries.